BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 22.07.2022

Real-Time Oncology Review; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Real-Time Oncology Review (RTOR)." The purpose of this guidance is to provide recommendations to applicants on the process for submission of selected new drug applications (NDAs) and biologics license applications (BLAs) with oncology indications for review under RTOR.

Source: Federal Register — Food and Drug AdministrationOpen original release →